重磅公告精选
1、$歌礼制药-B(01672.HK)$：3CLpro抑制剂ASC11有望成为治疗新冠肺炎的有效药物
歌礼制药-B发布公告，其口服小分子候选药物ASC11(3CLpro抑制剂)有望成为治疗新冠肺炎的有效药物。据悉，ASC11是利用包括分子模拟对接等专有技术自主研发的、靶点为3CLpro的口服小分子候选药物，拥有全球知识产权。
2、$伊泰煤炭(03948.HK)$一季度实现销售毛利54.75亿元，同比增长117.09%
伊泰煤炭公布，今年第一季度，销售收入121.43亿人民币，按年增加48.8%；销售成本66.68亿元，增加18.2%；销售毛利54.75亿元，增加117.1%。季内，煤炭产量1,239.67万吨，按年增加28.9%；销售煤炭1,731.74万吨，微增0.5%。
3、$中铝国际(02068.HK)$一季度新签合同额110.11亿元，同比增长50.32%
中铝国际发布公告，2022年第一季度，该公司新签合同1583个，新签合同金额为人民币110.11亿元，同比增长50.32%。
4、$李宁(02331.HK)$：第一季度同店销售按年取得20%-30%低段增长
从同店销售方面看，李宁（不包括李宁YOUNG）在整个平台的同店销售按年录得20%到30%的低段增长。在渠道方面，零售（直营）渠道录得20%到30%的中段增长，批发（特许经营）渠道录得10%到20%的低段增长。电商店铺业务按年增长为30%到40%的中段增长。
5、$中国铁塔(00788.HK)$一季度股东应占利润21.8亿元，同比增长28.7%
中国铁塔公布，今年第一季度，实现营业收入226.33亿人民币，按年增加7%。EBITDA录得156.82亿元，微增0.8%，EBITDA率69.3%。归属股东利润21.8亿元，增长28.7%。
保利协鑫能源(03800)与TCL科技拟共同投资120亿元建设光伏级和电子级硅料项目
中国金茂(00817)与中化保理订立新框架协议
五矿资源(01208)：Las Bambas将无法维持铜的生产
中国华融(02799)于北金所发布华融湘江银行股权转让信息 挂牌价119.807亿元
香港航天科技(01725)附属济南港航科与SDIISIT拟于农业卫星星座的建构及运营方面进行合作
康诺亚-B(02162)在研新药CMG901获美国FDA授予快速通道资格
中国生物制药(01177)：抗肿瘤药「盐酸安罗替尼胶囊」获批第五个适应症
百济神州(06160)：国家药监局批准百泽安®用于食管鳞状细胞癌的二线治疗
歌礼制药-B(01672)：3CLpro抑制剂ASC11有望成为治疗新冠肺炎的有效药物
百济神州(06160)：将在ASCO会议上公布3期临床试验RATIONALE-309的更新数据分析
复宏汉霖(02696)：HLX20用于晚期实体瘤治疗的1期临床研究结果显示其安全性及耐受性良好
三叶草生物-B(02197)：于2022年华盛顿世界疫苗大会展示新冠候选疫苗的最新持久性和加强针数据
361度(01361)：主品牌产品一季度零售额较上年同期取得高双位数增长
伊泰煤炭(03948)一季度实现销售毛利54.75亿元 同比增长117.09%
赤子城科技(09911)预期一季度社交业务收入6.25至6.5亿元 同比增长约65%
中铝国际(02068)一季度新签合同额110.11亿元 同比增长50.32%
李宁(02331)：第一季度同店销售按年取得20%-30%低段增长
中国铁塔(00788)一季度股东应占利润21.8亿元 同比增长28.7%
华电国际电力股份(01071)首季度累计完成发电量5608万兆瓦时 同比下降10.62%
山东新华制药股份(00719)发布首季度业绩 归母净利润约1.09亿元 同比增长8.20%
阳光能源(00757)一季度收入11.07亿元 同比增5.7%
中石化炼化工程(02386)一季度新签订合同总值313.7亿元 同比增加4.9%
中国铁建(01186)首季新签合同额4659.382亿元 同比增长1.53%
山东黄金(01787)发布第一季度业绩 归母净利约3.15亿元 同比扭亏为盈
中国太平(00966)：太平人寿一季度原保险保费561.74亿元
迅销(06288)中期股东应占溢利1468.44亿日圆 4月19日复牌
大悦城地产(00207)第一季度合同销售额约69.6亿元
联想控股(03396)发布附属联泓新科一季度业绩，营业收入15.56亿元
联想控股(03396)发布附属佳沃食品一季度业绩，归母净利润1.1亿元 同比扭亏为盈
华润医药(03320)附属东阿阿胶发盈喜，预期一季度归母净利润1亿元至1.2亿元
招商局港口(00144)累计18.94亿元场内增持上港集团 持股升至28.06%
友邦保险(01299)4月19日斥资约1.63亿港元回购208.08万股
渣打集团(02888)4月14日846万英镑回购167万股
金山软件(03888)4月19日耗资约996.74万港元回购43.3万股
明源云(00909)4月19日耗资约930.03万港元回购97万股
合景泰富集团(01813)就股份奖励计划发行109.32万股
因受限制股份单位获归属 嘉和生物-B(06998)发行1.625万股
小鹏汽车-W(09868)根据2019年股权激励计划而发行约7.375万股
思摩尔国际(06969)授出合共635.4万股奖励股份
贸易通(00536)授出740万份购股权
金山软件(03888)4月19日耗资996.7万港元回购43.3万股
赛生药业(06600)授出1804.6万份购股权及共241万股受限制股份单位
稻草熊娱乐(02125)授出合共385.9万个受限制股份单位
保利物业(06049)拟于8月5日派末期息每股0.305元
中国同辐(01763)将于7月23日派发末期股息每股37.79分
Selection of blockbuster announcements
1、$Golly Pharmaceuticals-B (01672.HK) $3CLpro inhibitor ASC11 is expected to be an effective drug in the treatment of COVID-19.
Golly Pharmaceutical-B announced that its oral small molecule drug candidate ASC11 (3CLpro inhibitor) is expected to become an effective drug for the treatment of COVID-19. It is reported that ASC11 is an oral small molecule drug candidate developed independently using proprietary technologies including molecular simulation docking and targeting 3CLpro, and has global intellectual property rights.
2、$Yitai Coal (03948.HK) $The gross profit of sales in the first quarter was 5.475 billion yuan, an increase of 117.09% over the same period last year.
Yitai Coal announced that in the first quarter of this year, sales revenue was 12.143 billion yuan, an annual increase of 48.8%; sales cost was 6.668 billion yuan, an increase of 18.2%; and sales gross profit was 5.475 billion yuan, an increase of 117.1%. During the quarter, coal production was 12.3967 million tons, an annual increase of 28.9 percent, and coal sales were 17.3174 million tons, a slight increase of 0.5 percent.
3、$Chinalco International (02068.HK) $The value of newly signed contracts in the first quarter was 11.011 billion yuan, an increase of 50.32% over the same period last year.
Chinalco International announced that in the first quarter of 2022, the company signed 1583 new contracts, with a new contract value of 11.011 billion yuan, an increase of 50.32% over the same period last year.
4、$Li Ning Co. Ltd. (02331.HK) $In the first quarter, same-store sales grew at a low rate of 20%, 50% and 30% year-on-year
In terms of same-store sales, same-store sales of Li Ning Co. Ltd. (excluding Li Ning Co. Ltd. YOUNG) across the platform recorded low annual growth of 20 to 30 per cent. In terms of channels, retail (direct) channels recorded middle growth of 20% to 30%, and wholesale (franchise) channels recorded low growth of 10% to 20%. The ecommerce store business is growing at a mid-year rate of 30% to 40%.
5、$China Tower Corporation (00788.HK) $The profit attributable to shareholders in the first quarter was 2.18 billion yuan, an increase of 28.7% over the same period last year.
China Tower Corporation announced that in the first quarter of this year, operating income reached 22.633 billion yuan, an annual increase of 7 percent. EBITDA recorded 15.682 billion yuan, a slight increase of 0.8%. The EBITDA rate was 69.3%. The profit attributable to shareholders was 2.18 billion yuan, an increase of 28.7%.
Poly Xiexin Energy (03800) and TCL Technology plan to jointly invest 12 billion yuan to build photovoltaic and electronic grade silicon projects.
China Jinmao (00817) signs a new framework agreement with Sinochem factoring
Minmetals Resources (01208): Las Bambas will not be able to maintain copper production
China Huarong (02799) issued by Beijing Gold Institute Huarong Xiangjiang Bank equity transfer information listed at 11.9807 billion yuan.
Jinan Port Aviation Division affiliated to Hong Kong Aerospace Science and Technology (01725) and SDIISIT plan to cooperate in the construction and operation of agricultural satellite constellations
Conoya-B (02162) was awarded fast track qualification by FDA in the United States in developing a new drug, CMG901.
Sino Biopharmaceutical (01177): antineoplastic drug "Anlotinib Hydrochloride capsule" was approved for the fifth indication.
BeiGene, Ltd. (06160): the State Drug Administration approved Bai Zean ®for second-line treatment of esophageal squamous cell carcinoma.
Golly Pharmaceutical-B (01672): 3CLpro inhibitor ASC11 is expected to be an effective drug in the treatment of COVID-19
BeiGene, Ltd. (06160): updated data analysis of phase 3 clinical trials RATIONALE-309 will be announced at the ASCO meeting.
Fu Hong Hanlin (02696): the results of phase 1 clinical study of HLX20 in the treatment of advanced solid tumor showed that it was safe and well tolerated.
Clover organism-B (02197): the latest persistence and enhanced needle data of COVID-19 's candidate vaccine will be presented at the 2022 World Vaccine Congress in Washington.
361degrees (01361): retail sales of main brand products achieved high double-digit growth in the first quarter compared with the same period last year.
Yitai Coal (03948) achieved a gross sales margin of 5.475 billion yuan in the first quarter, an increase of 117.09% over the same period last year.
Chizi City Technology (09911) expects social business revenue to increase by about 65% from 6.25 to 650 million yuan in the first quarter compared with the same period last year.
Chinalco International (02068) the newly signed contract value of 11.011 billion yuan in the first quarter increased by 50.32% over the same period last year.
Li Ning Co. Ltd. (02331): same-store sales in the first quarter grew by 20% per cent per year and 30 per cent year-on-year.
China Tower Corporation (00788) the profit attributable to shareholders in the first quarter was 2.18 billion yuan, up 28.7% from the same period last year.
Huadian International Power Co., Ltd. (01071) achieved a cumulative output of 56.08 million MW hours in the first quarter, down 10.62% from the same period last year.
Shandong Xinhua Pharmaceutical Co., Ltd. (00719) released first-quarter net profit of about 109 million yuan, an increase of 8.20% over the same period last year.
The revenue of Sunshine Energy (00757) in the first quarter was 1.107 billion yuan, an increase of 5.7% over the same period last year.
China Petroleum & Chemical Corp Refining and Chemical Engineering (02386) the total value of newly signed contracts in the first quarter was 31.37 billion yuan, an increase of 4.9% over the same period last year.
China Railway Construction Corporation (01186) newly signed contracts worth 465.9382 billion yuan in the first quarter, an increase of 1.53% over the same period last year.
Shandong Gold Mining (01787) released the return of the first quarter net profit of about 315 million yuan to profit compared with the same period last year.
China Taiping (00966): the original premium of Taiping Life Insurance was 56.174 billion yuan in the first quarter.
Fast Retailing (06288) medium-term profit attributable to shareholders 146.844 billion yen resumed trading on April 19th
The contract sales of Dayuecheng Real Estate (00207) in the first quarter is about 6.96 billion yuan.
Lenovo Holdings (03396) released its subsidiary Lianhong Xinke's first-quarter results, with operating income of 1.556 billion yuan.
Lenovo Holdings (03396) released the first-quarter results of affiliated Jiawo Foods, with a net profit of 110 million yuan compared with the same period last year.
East Ejiao hair Yingxi, affiliated to China Resources Pharmaceutical (03320), is expected to return to its mother with a net profit of 100 million yuan to 120 million yuan in the first quarter.
Increase and decrease holdings
China Merchants Port (00144) accumulated 1.894 billion yuan to increase its stake in Shanghai Port Group to 28.06%.
AIA Group Limited (01299) spent about HK $163 million to buy back 2.0808 million shares on April 19th.
Standard Chartered PLC (02888) 8.46 million pounds buyback 1.67 million shares on April 14
Kingsoft (03888) spent about HK $9.9674 million to buy back 433000 shares on April 19.
Ming Yuan Cloud Group (00909) spent about HK $9.3003 million to buy back 970000 shares on April 19.
Hop King Pacific Group (01813) issues 1.0932 million shares under the share Award Scheme
Due to the ownership of restricted shares in Jiahe Bio-B (06998), 16250 shares were issued.
XPeng Inc.-W (09868) issued about 73750 shares under the 2019 equity incentive plan
Smoore International Holdings Limited (06969) awarded a total of 6.354 million award shares
Tradelink (00536) granted 7.4 million share options
Jinshan Software (03888) spent HK $9.967 million to buy back 433000 shares on April 19th.
Sai Sheng Pharmaceutical (06600) granted 18.046 million share options and a total of 2.41 million restricted shares
Straw Bear Entertainment (02125) granted a total of 3.859 million restricted shares
Poly property (06049) plans to pay a final dividend of 0.305 yuan per share on August 5.
China Tongfu (01763) will pay a final dividend of 37.79 cents per share on July 23.
